CA2551900A1 - Novel pharmaceutical combinations containing scopine or tropic acid esters and egfr-kinase inhibitors - Google Patents

Novel pharmaceutical combinations containing scopine or tropic acid esters and egfr-kinase inhibitors Download PDF

Info

Publication number
CA2551900A1
CA2551900A1 CA002551900A CA2551900A CA2551900A1 CA 2551900 A1 CA2551900 A1 CA 2551900A1 CA 002551900 A CA002551900 A CA 002551900A CA 2551900 A CA2551900 A CA 2551900A CA 2551900 A1 CA2551900 A1 CA 2551900A1
Authority
CA
Canada
Prior art keywords
amino
quinazoline
phenyl
methoxy
chloro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002551900A
Other languages
English (en)
French (fr)
Inventor
Michael P. Pieper
Gerald Pohl
Birgit Jung
Michel Pairet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim International GmbH
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2551900A1 publication Critical patent/CA2551900A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
CA002551900A 2004-01-09 2005-01-04 Novel pharmaceutical combinations containing scopine or tropic acid esters and egfr-kinase inhibitors Abandoned CA2551900A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102004001607A DE102004001607A1 (de) 2004-01-09 2004-01-09 Neue Arzneimittelkombinationen auf der Basis von Scopin- oder Tropensäureestern mit EGFR-Kinase-Hemmern
DE102004001607.0 2004-01-09
PCT/EP2005/000009 WO2005065687A1 (de) 2004-01-09 2005-01-04 Neue arzneimittelkombinationen enthaltend scopin-oder tropensäureestern und egfr-kinase-hemmer

Publications (1)

Publication Number Publication Date
CA2551900A1 true CA2551900A1 (en) 2005-07-21

Family

ID=34744668

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002551900A Abandoned CA2551900A1 (en) 2004-01-09 2005-01-04 Novel pharmaceutical combinations containing scopine or tropic acid esters and egfr-kinase inhibitors

Country Status (5)

Country Link
EP (1) EP1706119A1 (de)
JP (1) JP2007517819A (de)
CA (1) CA2551900A1 (de)
DE (1) DE102004001607A1 (de)
WO (1) WO2005065687A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010054285A2 (en) 2008-11-10 2010-05-14 National Health Research Institutes Fused bicyclic and tricyclic pyrimidine compounds as tyrosine kinase inhibitors
AU2020242287A1 (en) 2019-03-21 2021-09-02 INSERM (Institut National de la Santé et de la Recherche Médicale) A Dbait molecule in combination with kinase inhibitor for the treatment of cancer
US20220229072A1 (en) 2019-06-04 2022-07-21 INSERM (Institut National de la Santé et de la Recherche Médicale) Use of cd9 as a biomarker and as a biotarget in glomerulonephritis or glomerulosclerosis
US20220401436A1 (en) 2019-11-08 2022-12-22 INSERM (Institute National de la Santé et de la Recherche Médicale) Methods for the treatment of cancers that have acquired resistance to kinase inhibitors
WO2021148581A1 (en) 2020-01-22 2021-07-29 Onxeo Novel dbait molecule and its use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10206505A1 (de) * 2002-02-16 2003-08-28 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und EGFR-Kinase-Hemmern
DE10203741A1 (de) * 2002-01-31 2003-08-14 Boehringer Ingelheim Pharma Neue Fluorencarbonsäureester, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel
US7405224B2 (en) * 2002-01-31 2008-07-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg Xanthenecarboxylates, processes for preparing them, and their use as pharmaceutical compositions
DE10203753A1 (de) * 2002-01-31 2003-08-14 Boehringer Ingelheim Pharma Neue Xanthencarbonsäureester, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel
DE10204462A1 (de) * 2002-02-05 2003-08-07 Boehringer Ingelheim Pharma Verwendung von Tyrosinkinase-Inhibitoren zur Behandlung inflammatorischer Prozesse

Also Published As

Publication number Publication date
WO2005065687A1 (de) 2005-07-21
JP2007517819A (ja) 2007-07-05
DE102004001607A1 (de) 2005-08-11
EP1706119A1 (de) 2006-10-04

Similar Documents

Publication Publication Date Title
US20030158196A1 (en) Pharmaceutical compositions based on anticholinergics and EGFR kinase inhibitors
US7776315B2 (en) Pharmaceutical compositions based on anticholinergics and additional active ingredients
US20050165013A1 (en) Pharmaceutical compositions containing anticholinergics and EGFR kinase inhibitors
US6608054B2 (en) Pharmaceutical compositions based on anticholinergics and endothelin antagonists
US20040058950A1 (en) Pharmaceutical compositions based on anticholinergics and PDE-IV inhibitors
US20100099651A1 (en) Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders
US20060030579A1 (en) Compounds for the treatment of proliverative processes
US20060239935A1 (en) Compositions for inhalation
US20100310477A1 (en) Pharmaceutical compositions based on anticholingerics and additional active ingredients
US20040002502A1 (en) Medicament combinations comprising heterocyclic compounds and a novel anticholinergic
CA2498911A1 (en) Tiotropium salts for reducing respiratory mortality rate
US20040048886A1 (en) Pharmaceutical compositions based on new anticholinergics and NK1 receptor antagonists
EP1539162A1 (de) VERFAHREN ZUR VERBESSERUNG DER FûHIGKEIT VON PATIENTEN, DIE AN EINER LUNGENERKRANKUNG LEIDEN, ZUR TEILNAHME AN UND NUTZUNG VON LUNGEN-REHABILITATIONSPROGRAMMEN
US20030203918A1 (en) Pharmaceutical composition comprising an anticholinergic and a heterocyclic compound
CA2476127C (en) New pharmaceutical compositions based on anticholinergics and egfr kinase inhibitors
AU2003242771B2 (en) Novel drug compositions based on novel anticholinergics and inhibitors of egfr-kinase
CA2551900A1 (en) Novel pharmaceutical combinations containing scopine or tropic acid esters and egfr-kinase inhibitors
CA2492026A1 (en) New pharmaceutical compositions based on new anticholinergics and pde-iv inhibitors
CA2441964C (en) New pharmaceutical compositions based on anticholinergics and endothelin antagonists
US20100015061A1 (en) Pharmaceutical Compositions Based on Anticholinergics and Andolast
US20050203088A1 (en) Medicament combinations based on scopine- or tropene acid esters with EGFR-kinase inhibitors
CA2430592C (en) New pharmaceutical compositions based on anticholinergics and dopamine agonists
KR20050016999A (ko) 신규한 항콜린제 및 ｅｇｆｒ-키나제의 억제제를 기초로한 신규한 약물 조성물
CA2597942A1 (en) Pharmaceutical compositions comprising anticholinergics and etiprednol
CA2515530A1 (en) New pharmaceutical compositions based on anticholinergics and inhibitors of tnf alpha synthesis or action

Legal Events

Date Code Title Description
FZDE Dead